Occurrence of multiple sclerosis in central Finland:: a regional and temporal comparison during 30 years

被引:45
|
作者
Sarasoja, T
Wikström, J
Paltamaa, J
Hakama, M
Sumelahti, ML
机构
[1] Univ Tampere, Sch Publ Hlth, Tampere 33101, Finland
[2] Cent Hosp Cent Finland, Dept Neurol, Jyvaskyla, Finland
[3] Helsinki Univ Hosp, Dept Neurol, FIN-00170 Helsinki, Finland
[4] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
来源
ACTA NEUROLOGICA SCANDINAVICA | 2004年 / 110卷 / 05期
关键词
multiple sclerosis; incidence; prevalence; diagnosis;
D O I
10.1111/j.1600-0404.2004.00326.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - We estimated the prevalence and incidence of multiple sclerosis (MS) in central Finland up to 2000. Rates were compared with those in other areas in Finland. Material and method - MS cases were identified in the hospital registry by ICD codes for demyelinating diseases from 1979 to 2000. Cases with definite MS were included. Incidence and prevalence were calculated with 95% CI and standardization was performed using direct method. Results - In 1993 prevalence was 59/10(5) (n = 153). Incidence in 1979-93 was 3.8/10(5) person-years (n = 126). Rates are similar to average in areas with known rates of MS in Finland but substantially less than the over twofold MS risk in the neighbouring district Seinajoki. Extended follow-up to 2000 in central Finland showed increasing prevalence up to 105/10(5) (n = 277) and a significant increase in incidence 1994-98 up to 9.2/10(5) (n = 105). At the same time the diagnostic use of MRI increased up to 97%. Conclusion - Central Finland represents an average risk area of MS when compared with other areas of Finland but still a high risk in global comparison. The recent rapid increase in both prevalence and incidence is largely accounted for by increased use of MRI.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 46 条
  • [41] Development of a primary cutaneous CD30(+) anaplastic large-cell T-cell lymphoma during treatment of multiple sclerosis with fingolimod
    Papathemeli, Despoina
    Graefe, Ronald
    Hildebrandt, Uwe
    Zettl, Uwe K.
    Ulrich, Jens
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (14) : 1888 - 1890
  • [42] Reliability of spatial-temporal gait parameters during dual-task interference in people with multiple sclerosis. A cross-sectional study
    Monticone, Marco
    Ambrosini, Emilia
    Fiorentini, Roberta
    Rocca, Barbara
    Liquori, Valentina
    Pedrocchi, Alessandra
    Ferrante, Simona
    GAIT & POSTURE, 2014, 40 (04) : 715 - 718
  • [43] Comparison of the lower limb inter-segmental coordination during walking between healthy controls and people with multiple sclerosis with and without fall history
    Salehi, Reza
    Mofateh, Razieh
    Mehravar, Mohammad
    Negahban, Hossein
    Tajali, Shirin
    Monjezi, Saeideh
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
  • [44] Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study
    Lars G. Hvid
    Egon Stenager
    Ulrik Dalgas
    Journal of Neurology, 2022, 269 : 4895 - 4908
  • [45] Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study
    Hvid, Lars G.
    Stenager, Egon
    Dalgas, Ulrik
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4895 - 4908
  • [46] Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency
    Lim, Han Hyuk
    Kim, Yoo Mi
    Lee, Gyung Min
    Yu, Jaehong
    Han, Heon-Seok
    Yu, Jeesuk
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2022, 37 (11)